在设计安全有效的通用肝素抗毒剂的外部触发免费充电可切换的阴离子体
Chanel C La1,2, Stephanie A Smith3, Manu Thomas Kalathottukaren1,4
1Centre for Blood Research, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Advanced healthcare materials
|March 27, 2024
概括
研究人员使用宏分子聚离子抑制剂 (MPI) 开发了一种全新的普用肝素解毒剂. 这些MPI有效地中和了所有肝素,为protamine提供了更安全的替代品,毒性降低,有效性提高.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 材料科学 材料科学 材料科学
背景情况:
- 血栓形成,或血块形成,造成严重的健康风险,如中风和肺栓塞.
- 肝素抗凝剂被广泛使用,但它们的解毒剂,前胺,在有效性和安全性方面存在局限性.
- 益胺的狭窄治疗窗口和潜在的并发症需要改进的肝素逆转剂.
研究的目的:
- 设计和合成一种具有广泛功效和降低毒性的通用肝素解毒剂.
- 探索可切换的质子化概念的阴离子连接体的肝素中和.
- 开发宏分子聚离子抑制剂 (MPI) 作为对现有肝素抗剂的优质替代品.
主要方法:
- 一个宏分子聚离子抑制剂 (MPI) 图书馆的合成和选.
- 在聚合物支架上组装具有可切换的质子状态的阴离子结合组.
- 在体外和体内研究,以评估开发的抗剂的疗效和血红相容性.
主要成果:
- 识别能够中和未分离肝素的MPI,LMWH和 fondaparinux.
- 与质氨酸相比,证明了氨酸结合活性和血红相容性的改善.
- 在临床前模型中验证通用肝素抗剂的有效性.
结论:
- 宏分子聚离子抑制剂代表了一个有前途的全方位氨酸抗剂的新类.
- 可切换的质子化策略使得开发高效和安全的肝素逆转剂成为可能.
- 这种新型的抗毒剂在治疗肝炎患者和减轻出血风险方面取得了重大进展.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
690
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
690
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Masking and Demasking Agents
2.4K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.4K
Antidotes
636
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
636
EDTA: Auxiliary Complexing Reagents
586
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
586
Depolarizing Blockers: Pharmocokinetics
325
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
325


